Literature DB >> 30772097

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities.

Craig A Elmets1, Craig L Leonardi2, Dawn M R Davis3, Joel M Gelfand4, Jason Lichten5, Nehal N Mehta6, April W Armstrong7, Cody Connor1, Kelly M Cordoro8, Boni E Elewski1, Kenneth B Gordon9, Alice B Gottlieb10, Daniel H Kaplan11, Arthur Kavanaugh12, Dario Kivelevitch13, Matthew Kiselica5, Neil J Korman14, Daniela Kroshinsky15, Mark Lebwohl10, Henry W Lim16, Amy S Paller17, Sylvia L Parra18, Arun L Pathy19, Elizabeth Farley Prater20, Reena Rupani21, Michael Siegel5, Benjamin Stoff22, Bruce E Strober23, Emily B Wong24, Jashin J Wu25, Vidhya Hariharan26, Alan Menter13.   

Abstract

Psoriasis is a chronic, inflammatory, multisystem disease that affects up to 3.2% of the US population. This guideline addresses important clinical questions that arise in psoriasis management and care, providing recommendations on the basis of available evidence.
Copyright © 2018 American Academy of Dermatology, Inc. All rights reserved.

Entities:  

Keywords:  alcohol; anxiety; cancer; cardiovascular disease; chronic obstructive pulmonary disease; clinical guidelines for psoriasis; comorbidities; congestive heart failure; depression; dermatology; diabetes; erectile dysfunction; guidelines; hyperlipidemia; hypertension; inflammatory bowel disease; malignancy; metabolic syndrome; obesity; obstructive sleep apnea; psoriasis; psoriatic arthritis; relationships; renal disease; sexual health; skin disease; smoking; uveitis; work productivity

Mesh:

Year:  2019        PMID: 30772097     DOI: 10.1016/j.jaad.2018.11.058

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  75 in total

1.  Updates in Psoriasis Management: Based on selected presentations from Maui Derm 2020, January 25-29, 2020, Maui, Hawaii.

Authors:  Jo Ann Lequang
Journal:  J Clin Aesthet Dermatol       Date:  2020-07-01

2.  Activated Platelets Induce Endothelial Cell Inflammatory Response in Psoriasis via COX-1.

Authors:  Michael S Garshick; Michael Tawil; Tessa J Barrett; Charissa M Salud-Gnilo; Michael Eppler; Angela Lee; Jose U Scher; Andrea L Neimann; Sanja Jelic; Nehal N Mehta; Edward A Fisher; James G Krueger; Jeffrey S Berger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-03-05       Impact factor: 8.311

3.  Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges.

Authors:  Sukhmani Pannu; David Rosmarin
Journal:  Am J Clin Dermatol       Date:  2021-02-15       Impact factor: 7.403

4.  Patient characteristics, treatment patterns and disease outcomes in patients with psoriatic arthritis followed in a combined Dermatology-Rheumatology clinic: a retrospective real-world study.

Authors:  Kalliopi Klavdianou; Maria Stavropoulou; Pantelis Panagakis; Marina Papoutsaki; Alexandros Panagiotopoulos; Christos Koutsianas; Alexandros Stratigos; Dimitrios Rigopoulos; Dimitrios Vassilopoulos
Journal:  Rheumatol Int       Date:  2022-04-18       Impact factor: 2.631

Review 5.  The role of xenobiotics in triggering psoriasis.

Authors:  Jasna Grželj; Marija Sollner Dolenc
Journal:  Arch Toxicol       Date:  2020-08-24       Impact factor: 5.153

6.  Screening for cardiovascular comorbidity in United States outpatients with psoriasis, hidradenitis, and atopic dermatitis.

Authors:  Partik Singh; Jonathan I Silverberg
Journal:  Arch Dermatol Res       Date:  2020-05-11       Impact factor: 3.017

7.  A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S).

Authors:  Joel M Gelfand; Daniel B Shin; Kristina Callis Duffin; April W Armstrong; Andrew Blauvelt; Stephen K Tyring; Alan Menter; Scott Gottlieb; Benjamin N Lockshin; Eric L Simpson; Farid Kianifard; Rajendra Prasad Sarkar; Elisa Muscianisi; Jennifer Steadman; Mark A Ahlman; Martin P Playford; Aditya A Joshi; Amit K Dey; Thomas J Werner; Abass Alavi; Nehal N Mehta
Journal:  J Invest Dermatol       Date:  2020-02-21       Impact factor: 8.551

Review 8.  Cardiovascular Risk in Patients With Psoriasis: JACC Review Topic of the Week.

Authors:  Michael S Garshick; Nicole L Ward; James G Krueger; Jeffrey S Berger
Journal:  J Am Coll Cardiol       Date:  2021-04-06       Impact factor: 24.094

9.  CCL20 in psoriasis: A potential biomarker of disease severity, inflammation, and impaired vascular health.

Authors:  Youssef A Elnabawi; Michael S Garshick; Michael Tawil; Tessa J Barrett; Edward A Fisher; Kristen Lo Sicco; Andrea L Neimann; Jose U Scher; James Krueger; Jeffrey S Berger
Journal:  J Am Acad Dermatol       Date:  2020-11-28       Impact factor: 11.527

Review 10.  Oral and Topical Vitamin D, Sunshine, and UVB Phototherapy Safely Control Psoriasis in Patients with Normal Pretreatment Serum 25-Hydroxyvitamin D Concentrations: A Literature Review and Discussion of Health Implications.

Authors:  Patrick J McCullough; William P McCullough; Douglas Lehrer; Jeffrey B Travers; Steven J Repas
Journal:  Nutrients       Date:  2021-04-29       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.